, Tracking Stock Market Picks
Enter Symbol:
Neurometrix, Inc. (NURO) [hlAlert]

down 82.02 %

Neurometrix, Inc. (NURO) rated Buy with price target $3 by Dawson James

Posted on: Monday,  Feb 27, 2012  9:25 AM ET by Dawson James

Dawson James rated Buy Neurometrix, Inc. (NASDAQ: NURO) on 02/27/2012, when the stock price was $4.95. Since
then, Neurometrix, Inc. has lost 82.02% as of 01/04/2016's recent price of $0.89.
If you would have followed this Dawson James's recommendation on NURO, you would have lost 82.02% of your investment in 1407 days.

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/27/2012 9:25 AM Buy
4.95 18.00
as of 12/31/2012
1 Week down  -8.51 %
1 Month down  -14.00 %
3 Months down  -29.50 %
1 YTD down  -47.87 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/27/2012 9:25 AM Buy
4.95 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy